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Abstract 
Background  
People with serious mental illness have greater mortality risk than the general population. They 
experience health care inequalities throughout life; it is not clear if this persists to end of life.  
Aim  
Assess the empirical evidence describing end of life care and place of death for people with serious 
mental illness. 
Design 
A systematic review of original, peer-reviewed research, following PRISMA guidelines. Data were 
analysed using a narrative synthesis approach.  
Data sources 
Five online databases (Embase, PsycArticles, PsycInfo, Medline, PubMed) and additional sources 
were searched (without time restriction) for primary research reporting health care utilisation in the 
last year of life or place of death in adults with serious mental illness. 
Results 
After full text screening, 23 studies were included. We found studies reporting hospital admissions, 
emergency department care, palliative care and GP visits at end of life. We found conflicting 
evidence for the association between serious mental illness and end of life care, although different 
patient groups, settings and measures were used across studies. People with serious mental illness 
were more likely to die in care homes than the general population. There were no patterns for other 
places of death.  
Conclusions 
The evidence was sparse and heterogeneous, demonstrating variability in patterns and reporting of 
health care use and with little consensus on where people with serious mental illness are likely to 
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die. Given that people with serious mental illness have increased mortality risk, this gap in the 
knowledge around end of life care outcomes is concerning; this area of research needs further 
development. 
Key words: mental disorders; systematic review; death; terminal care; delivery of health care  
Key statements 
What is already known about the topic? 
• People with serious mental illness have increased mortality risk and have worse experience 
of and access to health care 
• Little is known about the end of life care experiences of people with serious mental illness 
What this paper adds? 
• There has not been a systematic review of the evidence describing the end of life care of 
people with serious mental illness 
• This review shows that research in this topic has grown in recent years but there is lack of 
consensus among the literature 
• There is a conflict in the literature between what care is considered good and bad end of life 
in this population 
Implications for practice, theory or policy 
• Research in end of life care for people with serious mental illness is emerging but needs to 
develop consistent hypotheses around what good end of life care comprises in this 
population 
• Some of the assumptions for what represents good end of life care  in the general 
population (eg, place of death, hospitalisation at the end of life) may not be transferable to 
people with serious mental illness 
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Background 
It is well documented that people with serious mental illness have a lower life expectancy than the 
general population (1–4). Whilst people with serious mental illness are at greater risk of death from 
unnatural causes (including homicide, suicide and accidents) (5,6), most of the mortality gap is 
explained by deaths from natural causes (7–9). This suggests that people with serious mental illness 
might have a high need for palliative and end of life care. Inequalities in access to and provision of 
health care for people with serious mental illness have been previously reported (10–13), yet it is 
not clear if this inequity persists to end of life. Several reviews and theoretical papers have discussed 
end of life care for people with serious mental illness and have generally concluded that this 
population are underserved, yet acknowledge that there is a limited scientific evidence base to 
illustrate the health care circumstances and outcomes at end of life for these patients (14–17). A 
systematic review of empirical research is needed to evaluate and summarise the results and assess 
the quality of the existing evidence on end of life care outcomes in people with serious mental 
illness. 
Methods  
The aim of this study was to systematically review the empirical evidence assessing end of life care 
and place of death for people with serious mental illness. It was intended that exploring the health 
care people with serious mental illness receive at the end of life would highlight any end of life care 
inequalities this population face. Specifically, we aimed to explore what health care services people 
with serious mental illness utilised in the last 12 months of life and where deaths occurred. 
Study design 
A systematic literature review was conducted using the Centre for Reviews and Dissemination 
guidelines (18) and reported following the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) framework (19). Due to anticipated heterogeneity of the evidence, data 
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were analysed using a narrative synthesis approach (20). This study protocol is registered with the 
PROSPERO database (registration number: CRD42017072604). 
Eligibility criteria 
Inclusion criteria were: adults (18+ years) with a diagnosis of serious mental illness, who had died or 
were in the last year of life; reported either health care access/utilisation in the last year of life or 
place of death; original research published in peer reviewed journals; and full-texts articles available 
in English language.  
Studies were excluded if they reported only one place of death (eg, the sample all died in hospital) 
and if actual health care access/utilisation was not reported (eg, only hypothetical or preferred care 
was reported). Conference abstracts were excluded as adequate information was required to judge 
quality. Reviews, case reports/studies and grey literature were not included as previous reviews 
(14,15,17) have included such literature and the aim and novelty of this review was to review only 
empirical, primary evidence. Studies from low-income countries were excluded as health care 
systems are not comparable and people with serious mental illness are likely to face additional 
barriers to end of life care not present in middle and high income countries. 
Data sources 
The database interface OvidSP was used to jointly search Embase, PsycArticles, PsycInfo and Medline 
from inception to search date (March 2019) in an advanced keyword search. PubMed was also 
searched using free-text search terms (truncated if necessary, “*”) and Boolean operators (“OR”, 
“AND”). Free-text keyword search terms were used to run a standardised search strategy. The 
medical subject headings (MeSH terms) and synonyms were used in combination with the keywords 
where available. Minor adjustments were made for different databases. Search terms were limited 
to titles or abstracts. The search terms used for PubMed are included in the supplementary material. 
Hand searches were used to search the reference lists of any relevant reviews found throughout the 
search and any relevant references identified in eligible papers.  
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Study selection 
Published original research articles meeting the inclusion criteria were identified in the search. 
Duplicate references were removed using referencing software (Endnote X8). 
Title and abstract screening and full text screening were performed independently by two 
researchers (RW and NH). Any disagreements, at each stage, were resolved following discussion. 
Data extraction and quality assessment of included studies was then completed by two researchers 
(RW and NH). A standard data extraction form was used for all included studies (see supplementary 
material). 
Data analysis and synthesis 
Using the data extraction form, a comprehensive table of study characteristics and results was 
populated. Details of the study results of interest (health care use in the last year of life and/or place 
of death) were identified, from the table Results column, and used to inform the synthesis of the 
evidence. A narrative synthesis approach was used to describe the results of the included studies. 
Narrative synthesis has been described as a process of summarising and explaining the results of a 
systematic review; it aims to “tell the story” of the evidence found using text (20). Using this 
approach we collated and summarised the evidence for (1) health care in the last year of life and (2) 
place of death. Within each of these two outcomes, results were grouped and summarised by either 
type of health care service or by place of death, thus results across studies describing utilisation of a 
particular health service or a place of death are described collectively. 
Quality assessment 
Although studies were not excluded on the basis of quality, the quality of individual studies was 
assessed using the Standard Quality Assessment Criteria for Evaluating Primary Research Papers 
(21), as a tool appropriate for use on a heterogeneous collection of studies. For this quality measure, 
the 14 items are indicators of meeting different quality criteria, scored as “yes” (2), “partly” (1), “no” 
(0), or “not applicable”. The summary scores for each study were derived by calculating the total 
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score of relevant items (ie, all those not scored as “not applicable”) and dividing it by the total 
possible score (excluding “not applicable” items). Quality ratings ranged from 0-1.0. The assessment 
was completed independently by two researchers (RW and NH). Where scores differed, the central 
value was taken. Quality ratings were expressed as a percentage; over 80% was considered strong, 
above 70%, good, 50% or above, adequate, and below 50%, limited (22). Quality scores were 
compared across studies. 
Results  
Search results 
The literature search yielded 3625 references (after excluding duplicates). Following title and 
abstract screening, 180 full texts were assessed for eligibility. Twenty-three studies were included in 
the review (see Figure 1). 
 
Study characteristics  
Characteristics of the 23 included studies are presented in Table 1. Fourteen studies reported health 
care at end of life (23–36) and 13 studies reported place of death in patients with a serious mental 
illness (13,28,34–44) and. Four studies reported both outcomes (28,34–36). 
All studies were observational by design and were published between 1977 and 2019. All but two 
studies (28,40) used a comparator to assess place of death or end of life care, generally a cohort 
without serious mental illness, although two studies (24,32) used cohorts with serious mental illness 
not at the end of life as comparators. There was great variability in the size of the study sample from 
which the sample of people with serious mental illness. In two studies (28,32), the whole sample 
comprised eligible adult subjects with serious mental illness, whom were included in the synthesis of 
results, whilst other studies presented results for subsamples with serious mental illness from a 
Figure 1 PRISMA flow diagram of included studies 
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much larger denominator, for example, N=1746 cases with serious mental illness from a total sample 
of N=733904 (13).  
Most studies were from the USA (13,24,30–32,34,35,38) and Canada (29,36,43); the remaining 
studies were from Denmark (41,42), the UK (28,44), France (39), the Netherlands (25), Australia 
(27,33), New Zealand (23), Japan (40) and Taiwan (26,37). The mean/median age of subjects ranged 
between 47 and 79. Although adult subjects was an inclusion criteria for the review, two studies 
(29,36) included subjects aged 10 and over and one (25) included cases aged 17 and over. These 
studies were included as the majority of subjects were adults. Most studies’ samples had a male 
majority. The highest proportions of male subjects were 97% and 93% (31,34), however both of 
these studies used veteran populations. Only three studies had female majorities (36,39,44). 
Mental illness diagnoses were mixed and it was not feasible to restrict the review to studies that 
included only patients with a diagnosis of serious mental illness.  Nine studies included only patients 
with schizophrenia spectrum disorders (13,26,27,29–31,34,36,37), one included only patients with 
bipolar disorder (44) and all others were mixed samples. 
Four studies reported outcomes for deaths from natural causes (34,35,38,42), two for unnatural 
deaths (33,43) and six for a mixed sample of natural and unnatural deaths (24,28,36,40,41,44). One 
study described the sample’s cause of death as “non-sudden”, which was an inclusion criteria (25). 
The remaining studies did not report cause of death. 
The results are summarised in Table 2. 
Health care utilisation in the last year of life 
Studies describing health care utilisation in the last year of life for patients with serious mental 
illness encompassed various types of health care including: hospitalisation, clinic visits, general 
practice and palliative care. Three studies presented results describing general practice attendance 
at the end of life for patients with serious mental illness (29,33,36) with conflicting evidence for 
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rates of attendance. More evidence was found for hospital and emergency department use and 
palliative care. 
Hospital use 
Studies describing utilisation of hospital care in the last year of life offered mixed results. Assessing 
acute care in the last month of life, one study found 44.7% patients who died from natural causes 
and 18.7% who died from unnatural causes were admitted to hospital in the last month of life (28). 
Another study reported hospitalisations in the last month of life were more likely to be admitted 
through accident and emergency, compared to admissions prior to the last month of life (32). 
Comparing acute care in patients with serious mental illness to the general population, two studies 
reported that patients with serious mental illness were more likely to have hospital admissions in 
the last year of life (24,30). However, Cohen et al (30) reported that rates of admissions to a general 
medical facility, were comparable in patients with and without schizophrenia (51% and 50%, 
respectively). Furthermore, there was no significant difference in the length of hospital stay in the 
last month of life between cancer patients with and without schizophrenia (26). 
Several studies reported the opposite association; patients with serious mental illness were less 
likely to be admitted to hospital in the last six months (29) and the last month (35) of life, and were 
in hospital for shorter stays (29,31,32) than patients without serious mental illness. Patients who had 
schizophrenia and who died in hospital or at home were less likely to have been admitted in the last 
six months of life than decedents without schizophrenia (36). Assessing gender differences, Spilsbury 
et al (27) reported that female patients with schizophrenia were less likely to be admitted to hospital 
in the last year of life than female patients without schizophrenia (72.6% compared with 81.1%, 
p<0.001), although admission rates were generally high. However, this difference was not observed 
in men, although male patients with schizophrenia had longer inpatient stays (?̃? 8.1 days compared 
with ?̃? 4.5 days); a pattern than was not seen in female patients. 
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Results were also mixed regarding intensive care unit care. Two studies found that patients with 
serious mental illness were more likely to receive care in an intensive care unit in the last month of 
life, one which compared intensive care with that for patients with serious mental illness not at the 
end of life (32) and the other compared with decedents without serious mental illness (26). These 
findings were supported by Spilsbury et al (27), but in male patients only. Conversely, Lavin et al (35) 
reported that patients with serious mental illness were less likely to receive intensive care in the last 
30 days of life. Mixed findings were also evident for other hospital intervention. In one study, there 
was no significant difference in unanticipated surgery or invasive surgery in the last 30 days of life or 
prior to the last 30 days of life (OR=0.8, 95% CI 0.3-2.2) (32). However, Huang et al (26) reported 
than patients with serious mental illness were more likely to undergo invasive interventions (such as 
cardiopulmonary resuscitation, endotracheal intubation, mechanical ventilation, urinary 
catheterisation and feeding tube) in the last month of life than patients without serious mental 
illness, but were less likely to receive chemotherapy and generally less likely to receive diagnostic 
examinations (excluding panendoscopy). 
Emergency department 
One study reported that people with serious mental illness were more likely to visit the emergency 
department at the end of life than the general population (35) and two studies found no significant 
difference (24,27). Lavin et al (35) reported that patients with psychiatric illness were more likely to 
visit the emergency department at least once in the last 30 days of life than patients without 
(OR=1.64, 95% CI 1.30-2.08) and were more likely to have more emergency department visits 
(RR=1.38, 95% CI 1.02-1.88). In a study that stratified by gender, there was no significant difference 
between rates of emergency department attendance in the last year of life for patients with and 
without schizophrenia, although, for male patients, those without schizophrenia were more likely to 
make visits to the emergency department considered urgent, rather than non-urgent (27). Chang et 
al (24) reported that patients with serious mental illness had a median of two emergency 
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department visits (IQR 0-5) in the last 12 months of life, though this was not significantly different to 
the number of visits reported in patients with serious mental illness not in the last year of their life. 
Taking into consideration the cause of death, a study of acute care utilisation in the last month of life 
in patients with a variety of psychiatric diagnoses reported that 45.6% patients who died from 
natural causes and 26.6% patients who died from unnatural causes visited the emergency 
department in the last month of life (28). 
Palliative care 
Six studies reported receipt of palliative care (23,25–27,29,34), notably four of these were among 
the most recent studies found in this systematic review of the evidence. Results regarding palliative 
care were particularly mixed. 
From a sample of decedents who died non-sudden deaths, 14.9% received palliative care in the last 
month of life, however of those who had “psychiatric disorder”, 8.5% received palliative care (25). 
The rate of receipt of specialist palliative care in patients with serious mental illness was 0.5%, 
compared to 1.72% of the general population (23). 
Spilsbury et al (27) reported that patients with schizophrenia were less likely to be registered with 
specialist palliative care than patients without schizophrenia and were less likely to receive palliative 
care if they had died from cancer, chronic obstructive pulmonary disease or certain types of organ 
failure or neurological disorder. After adjusting for patient socioeconomic factors and cause of 
death, one study found that patients with schizophrenia were less likely to receive palliative care 
than those without schizophrenia (29). Mixed evidence was provided by Huang et al (26); cancer 
patients with schizophrenia were no more or less likely than cancer patients without schizophrenia 
to receive palliative care or hospice ward care in the last month of life, however patients with 
schizophrenia were less likely to have a palliative care consultation (OR=0.59, 95% CI 0.43-0.82). 
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One study found no significant difference in rates of hospice enrolment in patients with and without 
schizophrenia, however, patients with schizophrenia had longer hospice stays (mean number of 
days=107) than patients without schizophrenia (mean number of days=63), which approached 
statistical significance (p=0.05) (34).  
Place of death  
Hospital deaths 
In the 11 studies that reported place of death, hospital was the most prominent location mentioned 
in the evidence. This was partly because five studies compared deaths in hospital in-patients with 
serious mental illness with the general population (13,37–39,44). Though these papers explored in-
hospital mortality, where in-hospital deaths were compared with patients without serious mental 
illness, these comparative figures were extracted and studies included as descriptors of place of 
death. Several studies reported that patients with serious mental illness were more likely to die in 
hospital than patients without (13,38,44). This pattern was found for both patients with 
schizophrenia (5.2% patients with schizophrenia died in hospital compared with 3% patients without 
schizophrenia) (13) and bipolar disorder (9.7% of patients with bipolar disorder compared to 8.4% of 
patients without) (44). Sohn et al (38) also reported that, following acute myocardial infarction, 
patients with schizophrenia were more likely to die in hospital, after adjusting for patient-related 
factors (OR=1.72, 95% CI 1.02-2.90). Patients with schizophrenia were also more likely to die in an 
intensive care unit than patients without (24.1% compared to 14.1%, OR=1.56, 95% CI 1.08-2.24) 
(37). However, not all evidence supported this trend. In a mixed psychiatric population, patients with 
serious mental disorder were found to be less likely to die in hospital, although this association was 
somewhat attenuated by patient sociodemographic and clinical factors (OR=0.92, 95% CI 0.84-1.01) 
(38). Also in a mixed sample, Gervaix et al (39) reported that patients with serious mental disorder 
were less likely die in hospital, after adjusting for patient factors, including physical comorbidities 
(OR=0.87, 95% CI 0.86-0.87). 
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Other studies looking more widely at place of death also demonstrated conflicting conclusions 
around hospital deaths. In one study, patients with psychiatric illness were less likely to die in 
hospital than patients without (37% compared to 40%, OR=0.67 95% CI 0.60-0.75) (35). In another, 
patients with schizophrenia were significantly less likely, than patients without, to die in hospital 
(55.5% compared to 70.5% in a matched cohort, p<0.001); this pattern was evident for all causes of 
death except suicide (36). However, evidence was often weak or in support of no difference 
between patients with and without serious mental illness. In cancer patients, rates of hospital 
deaths were comparable in those with and without schizophrenia (27% and 26%, respectively) (34). 
Another study found no significant difference between patients with and without psychiatric 
disorders for deaths in the emergency department (4% and 6%, respectively) or deaths in hospital 
(11% and 7%, respectively) (42). 
Two studies assessed place of death in serious mental disorder populations without comparing with 
data from non-psychiatric samples (28,40). Hospital was the second most common place of death in 
a sample of patients with a range of psychiatric diagnoses (14%), after home deaths (62%) (40). 
Hitosugi et al (28) reported that, of these hospital deaths, 48% resulted from natural causes (40). In a 
sample of patients that died from natural causes, hospital was the most common place of death 
(52.7%). 
Home deaths 
Rates of home deaths varied in the studies between 2.2% (in cancer deaths) (36) and 74% (in sudden 
cardiac deaths) (42). Hitosugi (40) made no comparison with other patient groups but reported that 
62.4% of patients with a history of mental illness died at home. In a more recent study, home deaths 
were reported in 31.2% of adults with serious mental disorder who died from natural causes (28). 
There was mixed evidence demonstrating whether patients with serious mental illness were more or 
less likely to die at home than other populations. Small differences in home deaths between cancer 
patients with and without schizophrenia (33% compared with 36%, respectively) were reported by 
14 
 
Ganzini et al (34). In one study, the difference in home deaths between patients with and without 
“psychiatric illness” (35.6% and 34.1%, respectively) did not reach significance (OR=1.02, 95% CI 
0.92-1.14) (35) and in another, patients with “neuroses and character disorders” were more likely to 
die at home than all decedents (40% compared with 27%, respectively) and this difference was not 
statistically significant (41). However, in patients who died from sudden cardiac death, 74% of 
patients with serious mental illness died at home, compared to 62% of patients without serious 
mental illness, which approached statistical significance (p=0.06) (42). 
One study reported that although home deaths from all-cause mortality were comparable in 
patients with and without schizophrenia (8.8% and 8.2%, respectively), and rates of home deaths 
were comparable for deaths from respiratory and circulatory diseases, home deaths in cancer 
patients were lower in those with schizophrenia than without (2.3% compared with 6.3%, 
respectively) (36). 
Care home deaths 
Studies consistently reported the increased likelihood of dying in a nursing home/care home 
(terminology and setting varied across studies; nursing homes, care homes and other residential 
health and social care settings are collectively referred to as care homes here) in patients with 
serious mental illness.  
In the oldest of the included studies, Nielsen et al (41) reported that 17% of people with functional 
psychoses died in a care home, compared with 2% of all decedents. More recently, this pattern 
remained unchanged, as patients with serious mental illness who died from natural causes were 
found to be more likely to die in a care home than those without a diagnosis of serious mental illness 
(15% compared with 11% (OR=1.27, 95% CI 1.09-1.49)) (35). 
In all-cause deaths, patients with schizophrenia were more likely to die in a nursing home compared 
to a matched cohort of patients without schizophrenia (29.7% compared with 13.9%, respectively) 
(36). This pattern was seen in deaths from circulatory disease, cancer and respiratory disease. In 
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cause of death specific studies, patients with schizophrenia who died from cancer and sudden 
cardiac death were more likely to die in a care home than patients without a diagnosis of 
schizophrenia (34,42). 
In the studies that described care home deaths without a comparator, 4.3% of all-cause deaths in 
patients with various psychiatric diagnoses were reported to occur in a ‘healthcare facility’ that was 
not a hospital (40) and 10.4% of deaths from natural causes in patients with serious mental disorder 
were in a care home (28).  
Other places 
In patients with a range of psychiatric diagnoses, Hitosugi (40) reported that 20% died in ‘other 
locations’ whilst Wilson et al (28) found that 2.2% of deaths from natural causes occurred in ‘other 
locations’. One study reported that 1.7% of patients with psychiatric illness died in ‘other locations’ 
(35), and that this was the same for patients without psychiatric illness. However, another study 
reported lower rates of death in an unknown location in patients with schizophrenia compared to 
patients without schizophrenia (5% compared with 18%, respectively) (34). Similarly, patients with 
previous psychiatric disorder who died from sudden cardiac death were significantly less likely to die 
in a public place than those without a psychiatric disorder (3% compared to 19%, p<0.01) (42). 
Unnatural deaths 
Four studies reported place of death exclusively for deaths from unnatural causes (28,36,40,43). One 
study reported that, of the 25 patients in their sample with various psychiatric diagnoses who died in 
hospital or other healthcare facility, over half of deaths were the result of an accident (N=7), 
homicide (N=4) or suicide (N=2) (40). Martens et al (36) compared place of death in patients who 
died by suicide with and without a diagnosis of schizophrenia. Nearly half of patients with 
schizophrenia who died by suicide died in their home (47.8%) and a third (33.3%) died in hospital; 
this was not significantly different to patients who died from suicide without a diagnosis of 
schizophrenia. In a study describing place of death for patients who died by suicide and had had 
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contact (in the 12 months prior to death) with a mental health professional, ‘own home’ was the 
most common place of death (61.7%); this was the same for people who hadn’t had contact with a 
mental health professional (43). In a study with mixed psychiatric diagnoses, most patients who died 
from unnatural causes died at home (39.6%) or in ‘other’ places (described as outdoor spaces, 
addresses other than their home and other institutional buildings) (36.0%); no patients died in a 
hospice and only one died in a care home (28). 
Quality of studies 
The quality of studies was variable. The mean quality score using the Standard Quality Assessment 
Criteria for Evaluating Primary Research Papers (21) ranged between 0.455-0.945. Notably, the 
lowest quality score was the oldest study (41). All but five studies (23,24,27,33,41) were judged to 
be of strong quality (>80%) using the thresholds described by Millard et al (22). 
Discussion 
End of life care 
There was little consensus regarding an association between hospital in-patient care at the end of 
life in patients with serious mental illness, although more studies were found to support an 
association between less in-patient care at the end of life for patients with serious mental illness, 
than for patients without. However, due to the heterogeneity in the diagnoses, cause of death and 
type of hospital admission, it is not possible to conclude that patients with serious mental illness are 
less likely to be hospitalised in at the end of life. 
The lack of literature reporting palliative care in patients with serious mental illness corroborated 
previous reviews of the literature (45). Although, notably, the evidence that was found which 
described hospice and palliative care for patients with serious mental illness were published more 
recently, which suggests that this is an emerging area of research. 
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On the whole, little evidence was found to support differences between patients with and without 
serious mental illness in health care utilisation near the end of life, however, this is largely due to a 
lack of evidence and great heterogeneity in the literature. The inconsistencies found in this 
systematic review mirrors those found by the scoping review performed by Relyea et al (46), who 
concluded that that inconsistencies in practice and implementation signal a lack of policy 
development. 
Place of death  
Mixed results were observed for place of death in patients with serious mental illness. There was 
variety across these studies in terms of the diagnoses included in the samples, causes of death and 
setting and study design. We found studies that reported associations between serious mental 
illness and increased likelihood of dying in hospital, decreased likelihood and no association between 
serious mental illness and hospital deaths. One common feature amongst studies reporting an 
increased likelihood of dying in hospital (13,37,38,44) was that they were all investigating the risk of 
in-hospital mortality in patients with serious mental illness. Whereas, most studies that found a 
negative or no association between serious mental illness and hospital-deaths were studies where 
all cases and all controls were deceased and place of death was the outcome rather than in-hospital 
mortality. Two exceptions to this were Sohn et al (38), who reported differences between diagnoses 
in place of death and Gervaix e al (39), where no difference between hospital mortality in patients 
with and without serious mental disorder was reported. A potential explanation for these mixed 
results is the different perspectives on hospital deaths. The authors of one of the included studies 
stated that “less hospital care suggests these patients are most likely being underserved” (36). This 
challenges the perception that dying in hospital represents poor end of life care. The mixed results 
describing hospital deaths in patients with serious mental illness found in this review illustrate the 
variation in whether authors were investigating hospital deaths as a ‘bad death’ or as a marker of 
poor end of life care. Whilst hospital is the most common place of death for the general population 
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(47) and is generally considered a negative outcome, this is not transferable to patients with serious 
mental illness, as hospital deaths are linked with cause of death (28,40).  
One consistent finding regarding place of death was concerning care homes, which included nursing 
home and supported care facilities. Care home deaths were more common in patients with serious 
mental illness, for all causes. One potential explanation for this is, for many people with serious 
mental illness a care homes or similar institutional care setting is their usual place of care, and may 
be more likely to be their place of death, than the general population, who may be more likely to 
reside at home until their death or nearer to the end of life. However, though studies indicated care 
home deaths were higher in this population, on comparing rates with those of the general 
population reported in other studies (eg, in 2014, over 20% of deaths in England and Wales occurred 
in care homes (48)), the rates of care home deaths reported in the studies included in this review are 
considerably lower for patients with serious mental illness. This discrepancy points to the various 
definitions of care home used in the serious mental illness literature and that from the wider 
population, perhaps indicating that care home deaths cannot be directly compared in the two 
patient populations. Furthermore, age at death may play a role in the association between serious 
mental illness and care home deaths. In the general population, care home deaths usually occur in 
older age (49,50). As the average age at death is lower in people with serious mental illness than the 
general population (9,51) care home deaths may be comparatively lower in people with serious 
mental illness. 
Most studies did not report significant associations between serious mental illness and home deaths. 
Rates of home deaths varied greatly between studies and did not appear to be associated with 
population or setting. The evidence did indicate that dying in the home was associated with cause of 
death. Deaths from unnatural causes, including suicide, were associated with more home deaths 
(28,36,43). These results would suggest that assessment of place of death in this patient population 
should consider cause of death, as, due to the increased risk of unnatural death (1), place of death is 
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not an appropriate proxy measure for end of life care across all-cause mortality in this patient group. 
Furthermore, no consistent findings were found for ‘other’ places of death, which was likely to refer 
to a wide variety of settings across the different studies. One place of death notably missing from 
the literature was hospice. 
Strengths and limitations 
We aimed to identify the peer-reviewed, primary evidence describing place of death and end of life 
care in adults with serious mental illness but did not exclude studies whose aim did not mirror or 
own. As such, we included any study that measured either of these two outcomes. We were able to 
include data from studies not purposefully designed to report place of death or end of life care. 
Although this has implications for the interpretation of these data, as discussed above (eg, in-
hospital mortality) this widened the breadth of the included studies and enriched our data synthesis.  
It was decided to exclude grey literature from the review. Although this may be considered a 
limitation, this decision was taken because, first, previous reviews have included and been 
dominated by grey literature, guidelines and case studies (14,15,45,46). Second, our intention was to 
identify empirical, peer-reviewed evidence describing end of life care outcomes for patients with 
serious mental illness and assess whether this is or has been a research priority in the fields of 
psychiatry or palliative care research. Thus, we believe this review is novel in including only primary 
evidence, of which we were able to assess the quality using a methodological tool. The exclusion of 
non-English literature also presents a limitation to the review. 
One of the main limitations of the review is the heterogeneity and diversity of the included studies. 
Comparisons between study results were not always possible and, with the lack of consensus, it is 
not possible to explicitly answer the research question ‘where do people with serious mental illness 
die?’, rather, we achieved the aim of identifying the evidence and our review is a comprehensive 
synthesis and description of the results from the literature. Furthermore, one limitation was the 
range of diagnoses included. In order not to exclude some relevant studies, we took an inclusive 
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approach and there is variation amongst the populations included in this review. Some samples 
(35,39,43) included patients who had a psychiatric admission, contact or prescription, although 
these may have not been a diagnosis we initially intended to limit the review to, they were serious 
enough to warrant inpatient care, thus were included as they were considered serious mental 
illness. We restricted our search strategy to middle and high income countries to avoid making 
comparisons between countries with different economic resources and priorities. However, using a 
threshold of middle and high income counties, we included countries that were culturally diverse 
(eg, countries dichotomised by other labels, such as ‘East’ and ‘West’), which may have contributed 
to the heterogeneity amongst the results. 
Implications and recommendations 
Although a number of studies were found in this review, there was great discrepancy in the 
objectives of these studies and whether acute health care at the end of life is a favourable outcome 
or not in this patient group. Studies have explored patients’ preferences for end of life care in 
serious mental illness populations. One study concluded that, just as the general population have a 
wish to and are able to express their end of life care preferences, so too do patients with serious 
mental illness (52). In another study, no differences were observed between the end of life care 
preferences (regarding terminal cancer care and artificial life support) between patients with and 
without serious mental disorder (53). Research assessing both patient preferences and health care 
outcomes is needed in this patient population, this would help to address the divide between the 
two schools of thought regarding acute health care at the end of life and to ensure patients’ 
preferences are being met. Severity of mental disorder should also be considered as it may be 
associated with both preferences and access to services. 
Conclusion 
We found a lack of literature describing end of life care and place of death in patients with serious 
mental illness and little consensus among the published primary evidence. Given that patients with 
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serious mental illness have increased mortality risk, both from natural and unnatural causes, the fact 
that little is known about their care at end of life is particularly concerning. In order to ensure this 
vulnerable population do not face health care inequality at the end of life, a robust evidence base is 
needed urgently. We conclude that, although research in this area is gaining momentum, end of life 
care in people with serious mental illness has not been a research priority and a homogenous 
research strategy, with standardised definitions and objectives is needed.  
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Table 1 – Data extracted from included studies 
Reference Country Date data 
collection 
Study sample1 Patient 
characteristics2 
(N MH patients; 
MH diagnosis;  
N (%) deceased) 
Design/Setting Cause of 
death 
(natural/ 
unnatural/ 
mixed) 
Key findings Notes on 
comparator 
Quality 
Health care utilisation in last year of life 
Butler & 
O’Brien 
(2017) (23) 
New 
Zealand 
2008-2014 N=230708 N=29712; 
Mixed sample 
of adults with 
primary 
diagnosis of 
“serious and 
persistent 
mental illness”; 
Mortality not 
reported 
Retrospective 
study 
Unknown • Rate of SPC receipt in adults with SMI was 
0.5%, compared to 1.72% in general 
population. 
• Rate ratio for palliative care receipt for 
people with SMI, compared to general 
population = 0.29. ie, people with SMI are 
3.51 times less likely to receive SPC than 
general population. 
N=230571 adults 
from general 
population, 
without SPMI 
diagnosis 
0.695 
Chang, Pany 
& 
Obermeyer 
(2017) (24) 
USA 2005-2011 N=920223 
emergency 
department 
patients 
N=92 cases died 
within 15 days 
of discharge; 
Mixed sample 
including 
patients with 
depression, 
schizophrenia/ 
Retrospective 
case-control 
study using 
hospital data  
Mixed  • Cases (psychiatric patients that died within 15 
days ED discharge) had a median of 2 (IQR 0-
5) ED visits in last 12 months of life. This was 
not significantly higher than the number of ED 
visits controls had in the 12 months prior to 
ED discharge (median=1, IQR=0-2) (OR=1.10, 
p=0.063). 
• Cases had a median of 7 (IQR 2-15) clinic visits 
in the last 12 months of life. This was not 
N=92 patients 
with psychiatric 
illness who did 
not died within 15 
days discharge 
0.640 
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psychosis, 
mood disorders; 
All deceased 
significantly higher than the number of clinic 
visits controls had in the 12 months prior to 
ED discharge (median=6, IQR=3-10.25) 
(OR=1.01, p=0.405). 
• Cases had a median of 1 (IQR 0-3.25) 
inpatient admissions in the last 12 months of 
life. This was significantly higher than the 
number of inpatient admissions controls had 
in the 12 months prior to ED discharge 
(median=1, IQR=0-2) (OR=1.14, p=0.0355). 
Chochinov 
et al (2012) 
(29) 
Canada  1995-2008 N=15770 
decedents 
N=3943; 
Patients with 
schizophrenia; 
All deceased 
Matched cohort 
study using 
routine health 
data (age 10+) 
Not reported • GP visits in last 6 months of life higher in 
patients with schizophrenia after adjusting 
for geography, age at death, sex, cause of 
death, year of death (Adjusted Relative 
Risk=1.15, 95% CI 1.10-1.20) 
• Physician specialist visits higher in patients 
without schizophrenia after 
adjustments(ARR=0.72, 95% CI 0.67-0.77) 
• Hospitalisations higher in patients without 
schizophrenia after adjustment (ARR=0.79, 
95% CI 0.75-0.83) 
• Rate of inpatient hospital days higher in 
patients without schizophrenia after 
adjustment (ARR=0.80, 95% CI 0.73-0.87) 
• Home care higher in patients without 
schizophrenia after adjustment (ARR=0.56, 
95% CI 0.52-0.60) 
N=11827 
decedents 
without 
schizophrenia  
0.865 
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• Length of home care in days higher in patients 
without schizophrenia after adjustment 
(ARR=0.74, 95% CI 0.57-0.96) 
• Nursing home residence higher in patients 
with schizophrenia after adjustment 
(ARR=2.13, 95% CI 2.01-2.25) 
• Patients with schizophrenia more likely to see 
GPs and psychiatrists (p<0.01); all other 
specialisms seen more by patients without 
schizophrenia (p<0.01) 
• After adjusting for age at death, sex, region of 
residence, SEP, cause of death, place of 
death, and date of death, patients with 
schizophrenia were less likely to receive 
palliative care in last two years of life than 
matched cohort (OR=0.48, 95% CI 0.41-0.56) 
Cohen, 
Dembling & 
Schorling 
(2002) (30) 
USA 1986 N=18733 
decedents 
N=130; 
Schizophrenia; 
All deceased 
Data derived 
from National 
Mortality 
Followback 
Survey (deaths 
over 25 years) 
Not reported  • 93% patients with schizophrenia hospitalised, 
compared to 65% of patients without 
schizophrenia (p<.001). 
• However, 51% were hospitalised to general 
medical facility, compared with 50% patients 
without schizophrenia. 
N=18603 patients 
without 
schizophrenia 
0.865 
Copeland et 
al (2007) 
(31) 
USA 2001-2002 N=27798 N=943; 
Schizophrenia; 
All deceased 
Inpatient 
decedents in 
Veterans 
hospitals 
derived from 
Not reported  • 54.5% Patients without a schizophrenia 
diagnosis had a primary care clinic visit in last 
year of life, compared to 30.7% patients with 
a schizophrenia diagnosis (p<0.05) 
N=26855 patients 
without 
schizophrenia 
0.945 
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national 
veterans 
databases  
• 39.8% patients without a schizophrenia 
diagnosis had a speciality care clinic visit in 
last year of life, compared to 18.7% patients 
with a schizophrenia diagnosis (p<0.05) 
• 28.8% patients with a schizophrenia diagnosis 
had minimal inpatient care (≤4 days) in last 
year of life, compared to 13.9% patients 
without a schizophrenia diagnosis (p<0.05) 
Daumit et al 
(2016) (32) 
USA 1994-2004 N=253 
patients who 
had hospital 
admissions 
N=253; 
Serious mental 
illness defined 
as: 
schizophrenia, 
being disabled 
with diagnosis 
of bipolar 
disorder or 
major 
depression, or 
being disabled 
with another 
mental disorder 
and use of 
specialty mental 
health care; 
All deceased 
 
Case-crossover 
study including 
patients 
discharged from 
acute care 
hospitals 
identified from 
cohort of 
Medicaid 
beneficiaries 
Not reported • Hospitalisations within 30 days of death were 
associated with being admitted through ED; 
81% of admissions in last 30 days were 
admitted through ED, compared to 78% of 
admissions ≥30 days prior to death (p=0.05) 
• Length of stay was shorter in the last 30 days 
(7.4) compared to prior to last 30 days (but 
within 5 years of death) (13.1) (p<0.001) 
• Admissions in the last 30 days of life had 
higher associated Charlson Comorbidity Index 
than admissions prior to last 30 days of life 
(4.3 compared to 3.1, p<0.001) 
• Patient safety events were more prevalent in 
hospitalisations that occurred within 30 days 
of death than in those not within 30 days of 
death. Any safety events were more common 
in last 30 days (OR=3.7, 95% CI 1.4-10.3), and 
after removing medication events – the most 
Each participants’ 
admissions in the 
last 30 days of life 
(cases) were 
compared with 
their own 
admissions prior 
to last 30 days of 
life (controls) 
0.915 
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common type of events – the association was 
stronger (OR=5.9, 95% CI 3.2-10.7). 
• Unanticipated transfer to intensive care unit 
more frequent in the last 30 days of life 
(OR=4.4, 95% CI 2.2-8.8) 
• No significant difference in unanticipated 
surgery or invasive procedure 
De Leo et al 
(2013) (33) 
Australia  2006-2008 N=443 
decedents 
N=194; 
Patients with a 
“diagnosable 
psychiatric 
disorder”, 
including mood, 
psychotic, 
substance use 
and anxiety 
disorders; 
All deceased 
Case-control 
study of suicide 
deaths aged 
over 35; data 
collected from 
NOK and HCPs. 
Unnatural  • In males, 77.5% of patients with any 
psychiatric diagnosis visited their GP ≤3 
months prior to suicide, compared to 76.1% 
of males without a psychiatric diagnosis 
(OR=1.09, 95% CI 0.49-2.38). 
• In females, 75.6% of patients with any 
psychiatric diagnosis visited their GP ≤3 
months prior to suicide, compared to 75.0% 
of females without a psychiatric diagnosis 
(OR=1.03, 95% CI 0.28-3.86). 
25.1% of suicide 
deaths without 
psychiatric 
disorder 
0.665 
Evenblij et 
al (2019) 
(25) 
Netherlands 2015 N=5361 
decedents 
N=183; 
Patients with 
“psychiatric 
disorder”; 
All deceased 
Decedents with 
non-sudden 
deaths 
identified from 
national 
mortality data 
“Non- 
sudden” 
NB - % weighted stratification (by diagnosis) 
and patient sex, age, ethnicity and place and 
cause of death, such that they were 
representation of all deaths (nationally) during 
the study period 
• 8.5% patients with psychiatric disorder 
received palliative care in last month of life, 
compared to 4.6% of patients with dementia, 
• N=803 
decedents 
with dementia 
• N=918 
patients with 
health 
problems 
related to 
ageing 
0.889 
35 
 
7.5% patients with accumulation of health 
problems, 14.9% all deceased patients 
• 1.5% patients with psychiatric disorder 
received care from pain specialist in last 
month of life, compared to 0.3% of patients 
with dementia, 1.1% patients with 
accumulation of health problems, 2.5% all 
deceased patients 
• 34.7% patients with psychiatric disorder 
received care from psychiatrist/psychologist 
in last month of life, compared to 13.7% of 
patients with dementia, 5.7% patients with 
accumulation of health problems, 6.2% all 
deceased patients 
• N=5361 all 
patients died a 
non-sudden 
death 
(included 
patients with 
psychiatric 
disorder, 
dementia and 
health 
problems) 
Ganzini et al 
(2010) (34) 
USA 2003-2008 N=256 
decedents 
N=60;  
Schizophrenia/ 
schizoaffective 
disorder; 
All deceased 
Cancer 
decedents 
identified from 
US veterans 
database 
Natural NB – no timeframe specified 
• N=33 (55%) patients with schizophrenia were 
hospice enrolled, compared to N=102 (52%) 
patients without schizophrenia (x2 = 0.161, 
p=0.69) 
• Patients with schizophrenia had a mean 
hospice length of stay 107 days (SD 144) 
compared to 63 days (SD 96) for patients 
without schizophrenia (t= -1.97, p=0.05) 
• N=35 (58%) patients with schizophrenia had 
advanced directive, compared to N=110 
(56%) patients without schizophrenia (x2 = 
0.091, p=0.76) 
N=196 cancer 
decedents 
without 
schizophrenia 
0.860 
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• N=22 (37%) patients with schizophrenia had 
CPR order, compared to N=80 (41%) patients 
without schizophrenia (x2 = 0.33, p=0.51) 
• N=9 (15%) patients with schizophrenia had 
Physician Orders for Life Sustaining 
Treatment, compared to N=9 (5%) patients 
without schizophrenia (x2 = 7.61, p<0.01) 
Huang et al 
(2018) (26) 
Taiwan  1999-2012 N=8555 
decedents 
N=1911; 
Schizophrenia; 
All deceased 
Decedents 
diagnosed with 
colorectal, liver, 
lung, breast, 
oral or prostate 
cancer 
identified from 
database of 
National Health 
Insurance 
claims  
Not reported • Patients with schizophrenia had a mean 
length of stay in an acute ward of 18.3 days 
(SD 10.10) in the last month of life, compared 
to 17.9 days (SD 9.8) for patients without 
schizophrenia (p=0.193) 
• 26.7% patients with schizophrenia utilised ICU 
in last month of life, compared to 22.9% 
patients without schizophrenia (OR=1.21, 95% 
CI 1.07-1.36). The difference was significant 
for colorectal (OR=1.42, 95% CI 1.08-1.85) and 
liver cancer (OR=1.49, 95% CI 1.19-1.87) 
subgroups. 
• 17.4% patients with schizophrenia used 
palliative care in last month of life compared 
to 18.9% patients without schizophrenia 
(OR=1.03, 95% CI 0.90-1.19). There were no 
significant differences for any of the cancer-
specific subgroups. 
• 15.7% patients with schizophrenia had 
hospice ward care in last month of life 
N=7644 cancer 
decedents 
without 
schizophrenia 
0.85 
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compared to 15.6% patients without 
schizophrenia (OR=1.15, 95% CI 0.99-1.33). 
No significant difference for any of the cancer 
subgroups. 
• 2.7% patients with schizophrenia had 
palliative care consultation in last month of 
life compared to 4.5% patients without 
schizophrenia (OR=0.59, 95% CI 0.43-0.82). 
The difference was significant for breast 
(OR=0.27, 95% CI 0.10-0.75) and oral cancer 
(OR=0.32, 95% CI 0.10-0.98) subgroups. 
• 5.6% patients with schizophrenia had hospice 
home care in last month of life compared to 
5.4% patients without schizophrenia 
(OR=1.11, 95% CI 0.89-1.39). No significant 
diff for any of the cancer subgroups 
• 17.7% patients with schizophrenia had 
chemotherapy in last month of life compared 
to 28.1% patients without schizophrenia 
(OR=0.55, 95% CI 0.48-0.63). No significant 
difference for any of the cancer subgroups. 
Invasive interventions 
• Patients with schizophrenia more likely to 
have CPR (OR=1.34, 95% CI 1.15-1.57), 
endotracheal intubation (OR=1.22, 95% CI 
1.08-1.38), mechanical ventilation (OR=1.15, 
95% CI 1.03-1.29), urinary catheterisation 
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(OR=1.19, 95% CI 1.07-1.32) and feeding tube 
(OR=1.41, 95% CI 1.26-1.58) in last month of 
life. 
Advanced diagnostic examination 
• Patients with schizophrenia less likely to have 
CT/MRI/ sonography (OR=0.80, 95% CI 0.71-
0.89), bone scan (OR=0.62, 95% CI 0.50-0.76) 
and PET scan (OR=0.37, 95% CI 0.15-0.96) in 
last month of life. No difference found for 
panendoscopy.  
Lavin et al 
(2017) (35) 
USA 2010-2014 N=16214 
decedents 
N=1715; 
Mixed MH 
sample; 
patients had 
diagnosis of 
mood, anxiety 
and/or 
psychotic 
disorder or 
prescription 
medicines for 
psychiatric 
illness; 
All deceased 
Cases selected 
from state 
database of 
past inpatients 
Natural In analyses adjusted for patient and health care 
factors: 
• Compared to patients without psychiatric 
illness, patients with evidence of psychiatric 
illness were less likely to have any 
hospitalisation in the last 30 days of life 
(OR=0.59, 95% CI 0.51-0.68) 
• Compared to patients without psychiatric 
illness, patients with evidence of psychiatric 
illness were less likely to have any ICU care 
(OR=0.41, 95% CI 0.35-0.48) and spent fewer 
days in ICU (RR=0.88, 95% CI 0.79-0.97) in the 
last 30 days of life 
• Compared to patients without psychiatric 
illness, patients with evidence of psychiatric 
illness were more likely to have an ED visit 
(OR=1.64, 95% CI 1.30-2.08) and to have had 
N=14499 patients 
without evidence 
of psychiatric 
illness 
0.945 
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more ED visits (RR=1.38, 95% CI 1.02-1.88) in 
the last 30 days of life 
Martens, 
Chochinov 
& Prior 
(2013) (36) 
Canada  1995-2008 N=15770 
decedents 
N=3943;  
Schizophrenia; 
All deceased 
Cases and 
matched 
controls 
identified from 
routine health 
care system 
data repository 
Mixed Health care utilisation stratified by place of 
death 
NB – adjusted for patient factors 
For hospital deaths 
• GP visits were higher in patients with 
schizophrenia (RR=1.12, 95% CI 1.07-1.18). 
Physician specialist visits (RR=0.69, 95% CI 
0.64-0.75), inpatient hospital separation rate 
(RR=0.81, 95% CI 0.77-0.85) and inpatient 
hospital days (RR=0.90, 95% CI 0.80-1.00) 
were higher in patients without 
schizophrenia. 
Home deaths 
• GP visits were higher in patients with 
schizophrenia (RR=1.26, 95% CI 1.14-1.40). 
Inpatient hospital separation rate was higher 
in patients without schizophrenia (RR=0.82, 
95% CI 0.68-0.99). 
Deaths in nursing homes 
• Inpatient hospital days were higher in 
patients without schizophrenia (RR=0.80, 95% 
CI 0.67-0.95). 
Deaths in other locations 
• GP visits were higher in patients with 
schizophrenia (RR=1.33, 95% CI 1.18-1.50) 
N=11827 
decedents 
without 
schizophrenia 
0.945 
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Spilsbury et 
al (2018) 
(27) 
Australia  2009-2013 N=63508 
decedents 
N=1194; 
Schizophrenia; 
All deceased 
Decedents and 
matched cohort 
identified from 
national 
database 
Mixed  Emergency department attendance 
• 73.1% female decedents with schizophrenia 
presented at ED in last year of life, compared 
with 76.1% female decedents without 
schizophrenia (p=0.11). Also no significant 
difference in urgency between those 
with/without schizophrenia. 
• 72.7% male decedents with schizophrenia 
presented at ED in last year of life, compared 
to 72.5% male decedents without 
schizophrenia (p=0.93). Males without 
schizophrenia more likely to be 
urgent/emergency, less likely to be semi-
urgent/non-urgent (p<0.001). 
Hospital admissions 
• 72.6% female decedents with schizophrenia 
admitted compared to 81.1% female 
decedents without schizophrenia (p<0.001). 
71.9% male decedents with schizophrenia 
admitted compared to 70.2% male decedents 
without schizophrenia (p=0.410). 
• Female decedents with schizophrenia had 
longer stays (mean 7.7 days (SE 0.4)) 
compared with 5.1 days (SE 0.1) (p<0.001). 
Male decedents with schizophrenia had 
longer stays (mean 8.1 days (SE 0.5)) 
compared with 4.5 days (SE 0.1) (p<0.001) 
N=39265 
matched 
decedents 
without 
schizophrenia 
0.75 
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• Female decedents with schizophrenia less 
acute care (94.5% vs 96.4%), palliation (1.8% 
vs 2.9%), more likely to have psychogeriatric 
care (2.2% vs 0.2%) (p<0.001). Male 
decedents with schizophrenia less acute care 
(96.8% vs 97.2%), palliation (1.9% vs 2.3%), 
more likely to have psychogeriatric care (0.7% 
vs 0.2%) (p<0.001) 
• Female decedents with schizophrenia more 
likely to have emergency admission (54.4% vs 
31.8%, p<0.001). Male decedents with 
schizophrenia more likely to have emergency 
admission (56.5% vs 30.6%, p<0.001). 
• 1.9% Female decedents with schizophrenia 
stayed in ICU compared to 1.5% pts without 
schizophrenia (p=0.193). Female decedents 
with schizophrenia more likely to have 
ventilator support (1.4% vs 0.8%) (p=0.018). 
3.0% male decedents with schizophrenia 
stayed in ICU compared to 2.0% male 
decedents without schizophrenia (p=0.002). 
Male decedents with schizophrenia more 
likely to have ventilator support (1.9% vs 
1.5%) (p=0.074). 
Specialist palliative care 
• Decedents with schizophrenia less likely to be 
registered with specialist palliative care (6.5% 
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vs 15.8%, p<0.001), less likely to receive 
longer hours of care (mean 13.2 hrs/decedent 
vs 23.3 hrs/decedent, p<0.001), less likely to 
receive specialist palliative care if they had 
cause of death amenable to specialist 
palliative care (11.9% vs 24.7%, p<0.001) and 
were less likely to receive specialist palliative 
care if they had cancer (27.5% vs 40.4%, 
p<0.001). 
Non-palliative care 
• Patients with schizophrenia more likely to use 
centre based day care (11.1% vs 8.3%, 
p<0.001), client care coordination (11.1% vs 
8.3%, p=0.003), counselling (13.6% vs 11.1%, 
p=0.009), personal care (13.3% vs 11.3%, 
p=0.034) and social support (16.8% vs 10.9%, 
p<0.001). No significant difference for allied 
health care, assessment, domestic assistance, 
home maintenance, nursing care or respite 
care 
Wilson et al 
(2019) (28) 
England 2007-2013 N=1029 
decedents 
N=1029; 
Mixed sample 
including; 
Schizophrenia, 
schizoaffective 
disorder, 
bipolar affective 
Data drawn 
from linked 
clinical records, 
hospital data 
and mortality 
data 
Mixed  Natural cause of death 
• 47.3% had no admissions or A&E visits in last 
month of life, 37.6% both visited A&E and 
were admitted, 8% visited A&E and were not 
admitted, 7.1% did not visit A&E and were 
admitted 
Unnatural cause of death 
N/A 0.9 
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disorder, 
substance use 
disorders, 
depressive 
episode or 
recurrent 
depressive 
disorder; 
All deceased 
• 70.5% had no admissions or A&E visits in last 
month of life, 15.8% both visited A&E and 
were admitted, 10.8% visited A&E and were 
not admitted, 2.9% did not visit A&E and were 
admitted 
Place of death 
Daumit et al 
(2006) (13) 
USA 2001-2002 N=733904 
patients who 
had hospital 
admissions 
N=1746; 
Schizophrenia; 
5.2% deceased  
Patients had 
medical/ 
surgical 
hospitalisations 
for primary 
diagnoses other 
than 
schizophrenia 
Not reported • Hospital deaths were more common in 
patients with schizophrenia (5.2%) than 
patients without schizophrenia (3.0%), 
following medical or surgical admission. 
 
N=732158 
hospitalised 
patients without 
schizophrenia 
(3.0% deceased) 
0.945 
Ganzini et al 
(2010) (34) 
USA 2003-2008 N=256 
decedents  
N=60; 
Schizophrenia/ 
schizoaffective 
disorder; 
All deceased 
Cancer 
decedents 
identified from 
US veterans 
database 
Natural • 33% of patients with schizophrenia died at 
home, compared to 36% of patients without 
schizophrenia; 
• 27% of patients with schizophrenia died in 
hospital, compared to 26% of patients 
without schizophrenia; 
• 17% of patients with schizophrenia died in a 
skilled nursing unit, compared to 13% of 
patients without schizophrenia; 
N=196 cancer 
decedents 
without 
schizophrenia 
0.86 
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• 18% of patients with schizophrenia died in an 
assisted living facility, compared to 7% of 
patients without schizophrenia; 
• 5% of patients with schizophrenia died in an 
unknown location, compared to 18% of 
patients without schizophrenia 
Gervaix et al 
(2018) (39) 
France  2009-2013 N=17620770 
patients who 
had hospital 
admissions 
N=1159672; 
Mixed MH 
sample; 
patients who 
had been 
admitted to 
hospital at least 
once for MH 
illness; 
7.2% deceased 
Patients 
hospitalised for 
somatic reasons 
identified in 
hospital 
discharge 
database 
Not reported • 7.57% all patients with mental illness had in-
hospital deaths, compared with 7.44% all 
patients without a mental illness (Ratio=1.02) 
• 23.08% cancer patients with a mental illness 
had in-hospital deaths, compared with 
25.75% cancer patients without a mental 
illness (Ratio=0.90) 
• 12.45% diabetes patients with a mental illness 
had in-hospital deaths, compared with 
13.11% diabetes patients without a mental 
illness (Ratio=0.95) 
• 13.00% cardiovascular patients with a mental 
illness had in-hospital deaths, compared with 
13.13% cardiovascular patients without a 
mental illness in-hospital deaths (Ratio=0.99) 
• In a multivariable model, adjusted for sex, 
age, cardiovascular disease, diabetes, cancer, 
no of hospitalisations, severity of 
hospitalisations and deprivation, mental 
illness was associated with lower likelihood of 
in-hospital death (OR=0.87, 95% CI 0.86-0.87) 
• N=1225396 
patients 
without 
mental illness 
died in 
hospital 
• N=561543 
patients with 
cancer and 
without 
mental illness 
died in 
hospital 
• N=247894 
patients with 
diabetes and 
without 
mental illness 
died in 
hospital 
0.8 
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• N=940376 
patients with 
cardiovascular 
disease and 
without 
mental illness 
died in 
hospital 
Hitosugi 
(1999) (40) 
Japan 1990-1997 N=1107 
decedents 
N=141; 
Mixed MH 
sample 
including 
schizophrenia 
(27%), mood 
disorders (23%), 
amongst others; 
All deceased 
Cases selected 
from forensic 
autopsy cases 
of sudden or 
unnatural 
deaths 
Mixed 
28% natural; 
67% 
unnatural; 5% 
unknown 
• 62% patients died at home, 14% in hospital, 
4% in other healthcare facilities and 20% in 
‘other locations’ 
• Psychiatric diagnosis was not significantly 
associated with place of death (p>.05) 
• N=25 patients died in hospital/other 
healthcare facilities; N=12 (48%) of these 
patients died from natural deaths, N=13 
(52%) from unnatural causes 
N/A 0.825 
Lavin et al 
(2017) (35) 
USA 2010-2014 N=16214 
decedents 
N=1715; 
Mixed MH 
sample; 
patients had 
diagnosis of 
mood, anxiety 
and/or 
psychotic 
disorder or 
prescription 
Cases selected 
from state 
database of 
past inpatients 
Natural • Compared to patients without MH diagnosis, 
MH patients more likely to die in nursing 
home (15 % compared to 11%, OR=1.27, 95% 
CI 1.09-1.49) and less likely to die in hospital 
(37% compared to 40%, OR=0.67, 95% CI 
0.60-0.75). No significant differences between 
MH and non-MH patients in deaths at home, 
in hospice, or other locations. 
N=14499 
patients without 
evidence of 
psychiatric illness 
0.945 
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medicines for 
psychiatric 
illness; 
All deceased 
Martens, 
Chochinov 
& Prior 
(2013) (36) 
Canada  1995-2008 N=15770 
decedents 
N=3943;  
Schizophrenia; 
All deceased 
Cases identified 
from routine 
health care 
system data 
repository 
Mixed • Compared to decedents without 
schizophrenia, decedents with schizophrenia 
were more likely to die in a nursing home 
(30% compared to 14%) and less likely to die 
in hospital (56% compared to 71%) (p<.01). 
Deaths in homes and other locations were 
comparable. 
• Decedents with schizophrenia who died from 
circulatory disease were more likely to die in 
a nursing home (34% compared to 17%) and 
less likely to die in hospital (54% compared to 
69%) (p<.01). Deaths in homes and other 
locations were comparable. 
• Decedents with schizophrenia who died from 
cancer were more likely to die in a nursing 
home (20% compared to 5%) and less likely to 
die in hospital (76% compared to 86%) or at 
home (2% compared to 6%) (p<.01). Deaths in 
other locations were comparable. 
• Most deaths from suicide occurred in hospital 
or in the home, there was no significant 
difference between patients with or without 
schizophrenia (p=.16). 
N=11827 
decedents 
without 
schizophrenia 
0.945 
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• Decedents with schizophrenia who died from 
respiratory disease were more likely to die in 
a nursing home (33% compared to 20%) and 
less likely to die in hospital (61% compared to 
74%) (p<.01). Deaths at home or in other 
locations were comparable. 
• For all other causes of death, decedents with 
schizophrenia were more likely to die in a 
nursing home (32% compared to 19%) and 
less likely to die in hospital (50% compared to 
59%) or in other places (11% compared to 
15%) (p<.01). 
Nielsen, 
Homma & 
Biorn-
Henriksen 
(1977) (41) 
Denmark  1961-1976 N=738 
decedents  
Mixed MH 
sample: 
functional 
psychoses 
(N=29), neurosis 
& other 
character 
disorders 
(N=43) and 
other mental 
disorders 
(N=42); 
All deceased 
Deceased cases 
aged 65+ 
identified from 
a local database  
Mixed • 40% of patients with “neuroses and character 
disorders” died at home, compared with 27% 
of all decedents 
• 17% of patients with “functional psychoses” 
died in an “old people’s home”, compared 
with 2% of all decedents, 13% of patients with 
dementia, 20% of patients with 
cerebrovascular disorders, 5% of patients 
with no mental illness 
• N=738 
decedents 
(this includes 
MH patients) 
• N=170 
patients with 
dementia, 
N=25 patients 
with 
cerebrovascula
r disease, 
N=429 
patients with 
no mental 
illness  
0.455 
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Risgaard et 
al (2015) 
(42) 
Denmark  2000-2006 N=395 sudden 
cardiac 
decedents 
N=77; 
Mixed sample 
including 
schizophrenia 
and related 
disorders (40%) 
amongst others; 
All deceased 
National 
registry data 
used to identify 
sudden cardiac 
deaths in young 
adults (18-35) 
Natural  • Psychiatric patients significantly more likely to 
die in an “institution” (8% compared to 3% 
non-psychiatric patients, p=0.02) and less 
likely to die in a “public place” (3% compared 
to 19%, p<0.01). 
• Compared to non-psychiatric patients, more 
psychiatric patients died at home (74% 
compared to 62%), more died during 
hospitalisation (11% compared to 7%) and 
less died in the emergency department (4% 
compared to 6%) – these differences were 
not significant  
N=318 non-
psychiatric 
sudden cardiac 
deaths  
0.915 
Schaffer et 
al (2016) 
(43) 
Canada  1998-2011 N=2835 
suicide 
decedents 
N=1883; 
Mixed sample 
described as: 
Patients with a 
‘mental health 
contact’ in the 
12 months prior 
to death, 
including: a 
mental health 
related primary 
care outpatient 
physician 
contact, an 
outpatient 
Cases of suicide 
extracted from 
national registry 
data 
Unnatural • 62% of psychiatric patients died (from suicide) 
at home, compared to 69% of patients who 
had contact with a non-MH professional and 
65% of patients who had no health contacts 
• 3% of psychiatric patients died (from suicide) 
at ‘other residences’, compared to 2% of 
patients who had contact with a non-MH 
professional and 5% of patients who had no 
health contacts 
• 12% of psychiatric patients died (from suicide) 
outdoors, compared to 11% of patients who 
had contact with a non-MH professional and 
16% of patients who had no health contacts 
• 8% of psychiatric patients died (from suicide) 
at a subway/railway, compared to 4% of 
Compared with 
suicide 
completers who: 
• Had only non-
mental health 
care contact in 
last year of life 
(N=716) 
• Had no health 
care contacts 
in last year of 
life (N=236) 
0.945 
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psychiatric 
contact, a 
mental health 
related 
emergency 
department 
visit, a mental 
health related 
hospitalisation; 
All deceased 
patients who had contact with a non-MH 
professional and 4% of patients who had no 
health contacts 
• 16% of psychiatric patients died (from suicide) 
at ‘other’ locations, compared to 15% of 
patients who had contact with a non-MH 
professional and 9% of patients who had no 
health contacts 
Schoepf & 
Heun (2014) 
(44) 
UK 2000-2012 N=6831 
patients who 
had hospital 
admissions 
N=621; 
Bipolar 
disorder; 
N=60 (9.7%) 
deceased 
Admissions for 
≥24 hours 
extracted from 
hospital records 
for three local 
hospitals  
Mixed  • 9.7% patients with bipolar disorder who had 
had at least one general hospital admission 
died in hospital, compared to 8.4% patients 
without bipolar disorder 
• Patients with bipolar disorder who died in 
hospital had higher prevalence of 
hypertension, COPD, pneumonia, bronchitis, 
ischemic stroke than patients without bipolar 
disorder who died in hospital  
Compared to 
N=520 matched 
controls without 
bipolar disorder 
0.94 
Shen, Lu & 
Yang (2011) 
(37) 
Taiwan  2005-2007 N=2239 
intensive care 
patients 
N=203; 
Schizophrenia; 
24.1% deceased 
Study cohort of 
intensive care 
patients drawn 
from subset of 
the National 
Health 
Insurance 
Research 
Not reported • Patients with schizophrenia were more likely 
to die in ICU than patients without 
schizophrenia (24.1% compared to 14.1% of 
patients without schizophrenia, OR=1.56, 95% 
CI 1.08-2.24) 
Compared to 
N=2036 matched 
controls, 
intensive care 
patients without 
schizophrenia 
diagnosis 
0.94 
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Database, the 
Longitudinal 
Health 
Insurance 
Database of 
2005 
Sohn et al 
(2015) (38) 
USA 2010 N=42416 
patients with 
acute 
myocardial 
infarction 
N=16140; 
Mixed sample 
including:  
Schizophrenia 
Major affective 
disorders 
Substance 
abuse disorders 
Other mental 
disorders 
(excluding 
organic 
disorders, eg 
dementia) 
N=715 (4%) 
deceased 
Data drawn 
from Health 
Cost and 
Utilisation 
Project 
Natural  • 4% patients with mental disorder died in 
hospital, compared to 6% patients without 
mental disorder 
• In bivariate analysis, having any mental 
disorder was associated with lower odds of 
in-hospital mortality (unadjusted OR=0.71, 
95% CI 0.65-0.78), but was attenuated by 
gender, race, primary payer source, income, 
admission type and comorbidity index 
(adjusted OR=0.92, 95% CI 0.84-1.01) 
• Schizophrenia is a significant risk factor of in-
hospital mortality in acute myocardial 
infarction patients (after adjusting for 
covariates) (AOR=1.72, 95% CI 1.02-2.90), 
whereas substance abuse disorder has a 
protective effect (AOR=0.80, 95% CI 0.70-
0.91). Major affective disorders and other 
mental disorders not associated with in-
hospital mortality. 
N=26276 (N=715, 
4% deceased) 
patients without 
mental disorder 
diagnosis 
0.865 
 
Wilson et al 
(2019) (28) 
England 2007-2013 N=1029 
decedents 
N=1029; Data drawn 
from linked 
Mixed  Natural cause of death N/A 0.9 
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Mixed sample 
including; 
Schizophrenia, 
schizoaffective 
disorder, 
bipolar affective 
disorder, 
substance use 
disorders, 
depressive 
episode or 
recurrent 
depressive 
disorder; 
All deceased 
clinical records, 
hospital data 
and mortality 
data 
• Hospital most common place of death 
(52.7%), followed by home (31.2%), care 
home (10.4%), hospice (3.4%) and ‘other’ 
(2.2%) 
Unnatural cause of death 
• Home most common place of death (39.6%), 
followed by ‘other’ (36.0%), hospital (23.7%), 
care home (0.7%) and hospice (0%) 
 
1 Information on the entire sample reported in the study 
2 Information on the relevant patients included the review 
Abbreviations 
MH = mental health 
SPMI = serious persistent mental illness 
COPD = chronic obstructive pulmonary disorder 
ICU = intensive care unit 
SPC = specialist palliative care 
ED = emergency department 
A&E = accident & emergency 
SEP = socioeconomic position 
NOK = next of kin 
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HCP = health care professional 
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Table 2 - Summary of results found for each outcome (health care use in the last year of life and 
place of death) 
 
Health care use in the last year 
of life (23,24,33–36,25–32) 
Hospital (including ICU) 
(24,26–32,35,36) 
• Rates of hospital 
admission in the last 
year of life ranged 
from 18.7% to 72.6% 
• Two studies (24,30) 
reported that people 
with SMI were more 
likely to be admitted in 
the last year of life 
whilst six studies 
(27,29,31,32,35,36) 
reported lower 
hospital care, although 
there was great 
heterogeneity 
amongst these studies 
• Mixed evidence was 
found describing ICU 
care and other 
interventions at end of 
life 
Emergency department 
(24,27,28,35) 
• ED attendance varied 
according to cause of 
death and urgency of 
visit 
• One study (35) 
reported more ED 
attendance in people 
with SMI and two 
studies (24,27) 
reported no difference  
Palliative care (23,25–
27,29,34) 
• Four studies 
(23,25,27,29) reported 
that people with SMI 
were less likely to 
receive palliative care; 
mixed findings were 
reported by two 
studies (26,34) 
GP visits (29,33,36) • Two studies (29,36) 
reported that people 
with SMI were more 
likely to visit their GP; 
one study (33) 
reported no 
association 
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Place of death (13,28,42–
44,34–41) 
Hospital (13,28,44,34–40,42) • Between 4% and 61% 
deaths occurred in 
hospital 
• Four studies 
(13,37,38,44) reported 
an increased likelihood 
of dying in hospital for 
people with SMI and 
three studies 
(35,36,39) reported a 
lower likelihood of 
dying in hospital; two  
(34,42) reported no 
association 
• These associations 
varied by SMI 
diagnosis and by cause 
of death 
Home (28,34–36,40–43) • Very mixed evidence 
describing likelihood 
of dying at home, 
depending on 
population and cause 
of death  
• Wide variety in rates 
home deaths, ranging 
from 2.2% to 74% 
Care home (28,34–36,40–42) • Between 4.3% and 
29.7% deaths occurred 
in a care home 
• Studies consistently 
reported increased 
likelihood of dying in a 
care home (34–
36,41,42) 
Other (28,34–36,40,42,43) • Between 1.7% and 
20% deaths occurred 
in other locations 
• Great variability 
largely depending on 
cause of death 
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Figure 1 
 
 
 
  
Records identified through database 
searching (N=5356) 
Records identified through other 
sources (N=30) 
Records screened after duplicates 
removed (N=3625) 
Records excluded (N=3445) 
Full text articles assessed for 
eligibility (N=180) 
Full text articles excluded (N=157) 
- No relevant outcome (N=118) 
- Conference abstract only (N=22) 
- Full text not available in English (N=9) 
- Ineligible population (N=5) 
- Not primary research (N=2) 
- Duplicate (N=1) 
Included in data synthesis (N=23) 
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